Firefly Biologics

Acquired

Antibody Drug Conjugates Reimagined

Firefly Biologics is headquartered in South San Francisco, United States, lists 11–50 employees, and has $94.0M in recorded funding across 1 round.

Employees
11–50
Business Model
B2B
Total Funding
$94.0M
Last Round
$94.0M Series AMar 2024
Rounds
1
Acquisition Date
Jun 2026

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 7 investors for this company. The full record is or through the API.

About

Firefly Bio (dba Firefly Biologics) is a South San Francisco-based biotech developing Degrader Antibody Conjugates (DACs), a new therapeutic class combining the tumor-targeting precision of antibody-drug conjugates with selective protein degrader payloads. The company assembled a leadership team of veteran ADC researchers and is backed by Decheng Capital, MPM BioImpact, and Versant Ventures, having raised a $94 million Series A financing round to advance its pipeline.

Summary

Firefly Biologics is a Biotech company based in South San Francisco, United States. It lists 11–50 employees. It has raised $94.0M in total across 1 round, most recently a $94.0M Series A round in Mar 2024. Investors include Johnson & Johnson Innovation, Versant Ventures and MPM Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionJun 2026

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Firefly Biologics on Indexed.vc
<a href="https://indexed.vc/companies/firefly-biologics"><img src="https://indexed.vc/api/badge/company/firefly-biologics" alt="Firefly Biologics on Indexed.vc" width="260" height="76" /></a>